Abbott Laboratories
Price Chart
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
AI Research Brief
AI Generated- Regulatory Actions: Changes in healthcare regulations or adverse decisions from regulatory bodies could impact Abbott's product approvals and market access.
- Competitive Disruption: The rapid advancement of technology in medical devices could lead to disruptive innovations from competitors, impacting Abbott's market share.
- Customer Concentration: A significant portion of revenues may depend on key clients or contracts; loss of these could materially affect earnings.
- Upcoming product launches in the diabetes and cardiovascular segments that could significantly impact revenue growth and market perception.
- Quarterly earnings reports, particularly if they surpass analyst expectations, which could lead to upward revisions in stock price.
- Potential FDA approvals for new diagnostics products that would enhance Abbott's competitive positioning in the market.
Related Stocks
Ready to Invest in ABT?
Privacy Policy · Terms